References
PLAQUE
Flowchart of the study.Treatment effect measured by disparities in α-diversity demonstrated by Shannon and Simpson indices between placebo and probiotics after 14 days of sugar stress (Impact of sugar stress on predominant microbiota for the placebo and probiotic groups, respectively, and mean values of relative abundance of 15 predominant genera. X marks significant differences between groups. Intensity of coloration marks increasing abundance.Compositional changes induced by sugar stress. Principal component analysis (PCA) is expressed by the two most decisive components (PC1 and PC2), which covered approximately 15% of the variation of the dataset. Placebo vs. probiotics day 14 (Background information of the study population. Clinical data measured by plaque and BOP% by the mean and standard deviation (sd) for placebo and probiotics at baseline, day 14, and day 28.Salivary levels of IL-1β, IL-8, MIF, and MCP-1 expressed in pg/mL. Data are presented as the mean and standard deviation (sd) for the probiotic and placebo groups and Salivary levels of amylase activity, chitinase activity, total protease activity (TPA), and albumin concentration measured by slope/min, dF/dT, slope/sec and U/mL, and µg/mL, respectively. Data are presented as the mean and standard deviation (sd) for the probiotic and placebo groups and * Significant differences between groups.